{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:11:54Z","timestamp":1774617114004,"version":"3.50.1"},"reference-count":86,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FCT\/MCTES","award":["UIDP\/50017\/2020+UIDB\/50017\/2020+LA\/P\/0094\/2020"],"award-info":[{"award-number":["UIDP\/50017\/2020+UIDB\/50017\/2020+LA\/P\/0094\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Urinary tract infections (UTIs) caused by resistant Klebsiella pneumoniae can lead to severe clinical complications and even death. An alternative treatment option for infected patients is using bacteriophages. In the present study, we isolated phage VB_KPM_KP1LMA (KP1LMA) from sewage water using a K. pneumoniae strain as a host. Whole-genome analysis indicated that the genome was a double-stranded linear 176,096-bp long DNA molecule with 41.8% GC content and did not contain virulence or antibiotic resistance genes. The inactivation potential of phage KP1LMA was assessed in broth at an MOI of 1 and 10, and a maximum inactivation of 4.9 and 5.4 log CFU\/mL, respectively, was observed after 9 h. The efficacy at an MOI of 10 was also assessed in urine to evaluate the phage\u2019s performance in an acidic environment. A maximum inactivation of 3.8 log CFU\/mL was observed after 9 h. The results suggest that phage KP1LMA could potentially control a UTI caused by this strain of K. pneumoniae, indicating that the same procedure can be used to control UTIs caused by other strains if new specific phages are isolated. Although phage KP1LMA has a narrow host range, in the future, efforts can be made to expand its spectrum of activity and also to combine this phage with others, potentially enabling its use against other K. pneumoniae strains involved in UTIs.<\/jats:p>","DOI":"10.3390\/antibiotics13020195","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T05:39:56Z","timestamp":1708321196000},"page":"195","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Potential of an Isolated Bacteriophage to Inactivate Klebsiella pneumoniae: Preliminary Studies to Control Urinary Tract Infections"],"prefix":"10.3390","volume":"13","author":[{"given":"Jo\u00e3o","family":"Duarte","sequence":"first","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro, Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro, Portugal"}]},{"given":"Carolina","family":"M\u00e1ximo","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro, Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro, Portugal"}]},{"given":"Pedro","family":"Costa","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro, Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-0851","authenticated-orcid":false,"given":"Vanessa","family":"Oliveira","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro, Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1934-0091","authenticated-orcid":false,"given":"Newton C. M.","family":"Gomes","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro, Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4786-4773","authenticated-orcid":false,"given":"Jes\u00fas L.","family":"Romalde","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Parasitology, CRETUS & CIBUS, Faculty of Biology, University of Santiago de Compostela, CP 15782 Santiago de Compostela, Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9209-7687","authenticated-orcid":false,"given":"Carla","family":"Pereira","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro, Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8422-8664","authenticated-orcid":false,"given":"Adelaide","family":"Almeida","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro, Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2017). Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"106679","DOI":"10.1016\/j.ijantimicag.2022.106679","article-title":"Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime\/avibactam, meropenem\/vaborbactam, and comparators against these isolates: Results from the antimicrobial testing leadership and surveillan","volume":"60","author":"Lee","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1038\/s41467-022-30717-6","article-title":"Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen","volume":"13","author":"Gorrie","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_4","unstructured":"European Center for Disease Prevention and Control, and World Health Organization (2023). Annual Epidemiological Report for 2019: Healthcare\u2014Associated Infections Acquired in Intensive Care Units, World Health Organization."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Karampatakis, T., Tsergouli, K., and Behzadi, P. (2023). Carbapenem-resistant Klebsiella pneumoniae: Virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020234"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Guerra, M.E.S., Destro, G., Vieira, B., Lima, A.S., Ferraz, L.F.C., Hakansson, A.P., Darrieux, M., and Converso, T.R. (2022). Klebsiella pneumoniae biofilms and their role in disease pathogenesis. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.877995"},{"key":"ref_7","unstructured":"European Center for Disease Prevention and Control and World Health Organization (2023). Antimicrobial Resistance Surveillance in Europe, World Health Organization."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/antibiotics3020174","article-title":"Antimicrobial stewardship and urinary tract infections","volume":"3","author":"Abbo","year":"2014","journal-title":"Antibiotics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Liu, C., Hong, Q., Chang, R.Y.K., Kwok, P.C.L., and Chan, H.-K. (2022). Phage\u2013antibiotic therapy as a promising strategy to combat multidrug-resistant infections and to enhance antimicrobial efficiency. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050570"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2041","DOI":"10.1002\/rmv.2041","article-title":"The dawn of phage therapy","volume":"29","author":"Rehman","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.euf.2016.08.006","article-title":"Urinary tract infections in immunocompromised patients with diabetes, chronic kidney disease, and kidney transplant","volume":"2","author":"Tandogdu","year":"2016","journal-title":"Eur. Urol. Focus"},{"key":"ref_13","unstructured":"European Center for Disease Prevention and Control (2018). Annual Epidemiological Report for 2018: Healthcare- Associated Infections Acquired in Intensive Care Units, World Health Organization."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/phage.2023.0024","article-title":"Phage therapy in the management of urinary tract infections: A comprehensive systematic review","volume":"4","author":"Hooey","year":"2023","journal-title":"Phage"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sybesma, W., Zbinden, R., Chanishvili, N., Kutateladze, M., Chkhotua, A., Ujmajuridze, A., Mehnert, U., and Kessler, T.M. (2016). Bacteriophages as Potential treatment for urinary yract infections. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00465"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ujmajuridze, A., Chanishvili, N., Goderdzishvili, M., Leitner, L., Mehnert, U., Chkhotua, A., Kessler, T.M., and Sybesma, W. (2018). Adapted Bbacteriophages for treating urinary tract infections. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01832"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e0003723","DOI":"10.1128\/aac.00037-23","article-title":"Therapeutic potential of intravenous phage as standalone therapy for recurrent drug-resistant urinary tract infections","volume":"67","author":"Le","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lafor\u00eat, F., Antoine, C., Blasdel Reuter, B., Detilleux, J., Pirnay, J.-P., Brisse, S., Fall, A., Duprez, J.-N., Delcenserie, V., and Thiry, D. (2022). In vitro and in vivo assessments of two newly isolated bacteriophages against an ST13 urinary tract infection Klebsiella pneumoniae. Viruses, 14.","DOI":"10.3390\/v14051079"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15188","DOI":"10.1038\/s41598-023-42505-3","article-title":"Bacteriophages with depolymerase activity in the control of antibiotic resistant Klebsiella pneumoniae biofilms","volume":"13","author":"Zurabov","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lin, J., Du, F., Long, M., and Li, P. (2022). Limitations of phage therapy and corresponding optimization strategies: A review. Molecules, 27.","DOI":"10.3390\/molecules27061857"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Patient, S., and Zhang, B. (2022). Comparison of two distinct subpopulations of Klebsiella pneumoniae ST16 co-occurring in a single patient. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02624-21"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s11262-019-01681-z","article-title":"Biological properties and genomics analysis of vB_KpnS_GH-K3, a Klebsiella phage with a putative depolymerase-like protein","volume":"55","author":"Cai","year":"2019","journal-title":"Virus Genes"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Majkowska-Skrobek, G., Latka, A., Berisio, R., Squeglia, F., Maciejewska, B., Briers, Y., and Drulis-Kawa, Z. (2018). Phage-borne depolymerases decrease Klebsiella pneumoniae resistance to innate defense mechanisms. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02517"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Obradovi\u0107, M., Male\u0161evi\u0107, M., Di Luca, M., Keki\u0107, D., Gaji\u0107, I., McAuliffe, O., Neve, H., Stanisavljevi\u0107, N., Vukoti\u0107, G., and Koji\u0107, M. (2023). Isolation, characterization, genome analysis and host resistance development of two novel lastavirus phages active against pandrug-resistant Klebsiella pneumoniae. Viruses, 15.","DOI":"10.3390\/v15030628"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage Therapy: A Renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14111157","article-title":"Phage therapy in the 21st century: Is there modern, clinical evidence of phage-mediated efficacy?","volume":"14","author":"Abedon","year":"2021","journal-title":"Pharmaceuticals"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e0207121","DOI":"10.1128\/aac.02071-21","article-title":"Considerations for the use of phage therapy in clinical practice","volume":"66","author":"Suh","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","first-page":"176","article-title":"Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses","volume":"69","author":"Herridge","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"ref_29","first-page":"1","article-title":"Factors affecting plaque formation by bacteriophages","volume":"5","author":"Mullan","year":"2002","journal-title":"Dairy Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-60327-164-6_17","article-title":"Bacteriophage plaques: Theory and analysis","volume":"Volume 501","author":"Abedon","year":"2009","journal-title":"Bacteriophages"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yoo, S., Lee, K.-M., Kim, N., Vu, T.N., Abadie, R., and Yong, D. (2024). Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae. Microbiol. Spectr., 12.","DOI":"10.1128\/spectrum.01258-23"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.kjs.2023.01.012","article-title":"Isolation and characterization of lytic bacteriophage from waste water to control clinical multidrug resistant Klebsiella pneumoniae","volume":"50","author":"Shah","year":"2023","journal-title":"Kuwait J. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/phage.2020.0046","article-title":"Isolation and characterization of Klebsiella phages for phage therapy","volume":"2","author":"Townsend","year":"2021","journal-title":"Phage"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bai, J., Zhang, F., Liang, S., Chen, Q., Wang, W., Wang, Y., and Mart, A.J. (2022). Isolation and characterization of vB _ kpnM _ 17-11, a novel phage efficcient against carbapenem- resistant Klebsiella pneumoniae. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.897531"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Burrowes, B., Molineux, I., and Fralick, J. (2019). Directed in vitro evolution of therapeutic bacteriophages: The appelmans protocol. Viruses, 11.","DOI":"10.3390\/v11030241"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Li, N., Zeng, Y., Bao, R., Zhu, T., Tan, D., and Hu, B. (2021). Isolation and characterization of novel phages targeting pathogenic Klebsiella pneumoniae. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.792305"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1096995","DOI":"10.1080\/21597081.2015.1096995","article-title":"Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa","volume":"6","author":"Mapes","year":"2016","journal-title":"Bacteriophage"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e00929-22","DOI":"10.1128\/jvi.00929-22","article-title":"Host range expansion of Shigella phage Sf6 evolves through point mutations in the tailspike","volume":"96","author":"Subramanian","year":"2022","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e964081","DOI":"10.4161\/21597073.2014.964081","article-title":"Phage fitness may help predict phage therapy efficacy","volume":"4","author":"Lindberg","year":"2014","journal-title":"Bacteriophage"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Baqer, A., Fang, K., Mohd-Assaad, N., Adnan, S., and Nor, N. (2023). In vitro activity, stability and molecular characterization of eight potent bacteriophages infecting carbapenem-resistant Klebsiella pneumoniae. Viruse, 15.","DOI":"10.3390\/v15010117"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chen, C., Li, T., and Chen, H. (2023). Isolation and characterization of novel bacteriophage vB_KpP_HS106 for Klebsiella pneumoniae K2 and applications in foods. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1227147"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Balc\u00e3o, V.M., Moreli, F.C., Silva, E.C., Belline, B.G., Martins, L.F., Rossi, F.P.N., Pereira, C., Vila, M.M.D.C., and da Silva, A.M. (2022). Isolation and molecular characterization of a novel lytic bacteriophage that inactivates MDR Klebsiella pneumoniae strains. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14071421"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"127104","DOI":"10.1016\/j.micres.2022.127104","article-title":"Genomic characterization of lytic bacteriophages A\u00a5L and A\u00a5M infecting ESBL K. pneumoniae and its therapeutic potential on biofilm dispersal and in-vivo bacterial clearance","volume":"262","author":"Asghar","year":"2022","journal-title":"Microbiol. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e00362-12","DOI":"10.1128\/mBio.00362-12","article-title":"A Quorum-sensing-induced bacteriophage defense mechanism","volume":"4","author":"Svenningsen","year":"2013","journal-title":"MBio"},{"key":"ref_47","unstructured":"Hyman, P., and Abedon, S.T. (2009). Bacteriophages: Methods in Molecular Biology, Humana Press."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"199126","DOI":"10.1016\/j.virusres.2023.199126","article-title":"BL02, a phage against carbapenem- and polymyxin-B resistant Klebsiella pneumoniae, isolated from sewage: A preclinical study","volume":"331","author":"Liang","year":"2023","journal-title":"Virus Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e04761-22","DOI":"10.1128\/spectrum.04761-22","article-title":"Characterization of 29 newly isolated bacteriophages as a potential therapeutic agent against IMP-6-producing Klebsiella pneumoniae from clinical specimens","volume":"11","author":"Kondo","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-5193(05)80375-3","article-title":"Selection for lysis inhibition in bacteriophage","volume":"146","author":"Abedon","year":"1990","journal-title":"J. Theor. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Gallet, R., Shao, Y., and Wang, I.-N. (2009). High adsorption rate is detrimental to bacteriophage fitness in a biofilm-like environment. BMC Evol. Biol., 9.","DOI":"10.1186\/1471-2148-9-241"},{"key":"ref_52","first-page":"85","article-title":"The effect of cell size on the burst size of T4 bacteriophage infections of Escherichia coli B23","volume":"14","author":"Choi","year":"2010","journal-title":"J. Exp. Microbiol. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Droubogiannis, S., and Katharios, P. (2022). Genomic and biological profile of a novel bacteriophage, Vibrio phage virtus, which improves survival of Sparus aurata larvae challenged with Vibrio harveyi. Pathogens, 11.","DOI":"10.3390\/pathogens11060630"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1128\/AEM.67.9.4233-4241.2001","article-title":"Bacteriophage latent-period evolution as a response to resource availability","volume":"67","author":"Abedon","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e02220-21","DOI":"10.1128\/spectrum.02220-21","article-title":"Characterization of a T4-like bacteriophage vB_EcoM-Sa45lw as a potential biocontrol agent for Shiga toxin-producing Escherichia coli O45 contaminated on mung bean seeds","volume":"10","author":"Liao","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jmii.2023.07.012","article-title":"Isolation and characterization of bacteriophages with activities against multi-drug-resistant Acinetobacter nosocomialis causing bloodstream infection in vivo","volume":"56","author":"Lai","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/1751-7915.12090","article-title":"Influence of environmental variables in the efficiency of phage therapy in aquaculture","volume":"7","author":"Silva","year":"2014","journal-title":"Microb. Biotechnol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3354\/dao037033","article-title":"Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail","volume":"37","author":"Nakai","year":"1999","journal-title":"Dis. Aquat. Organ."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Pereira, C., Duarte, J., Costa, P., Braz, M., and Almeida, A. (2022). Bacteriophages in the control of Aeromonas sp. in aquaculture systems: An integrative view. Antibiotics, 11.","DOI":"10.3390\/antibiotics11020163"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virusres.2015.10.025","article-title":"Potential of phage cocktails in the inactivation of Enterobacter cloacae\u2014An in vitro study in a buffer solution and in urine samples","volume":"211","author":"Pereira","year":"2016","journal-title":"Virus Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e0034522","DOI":"10.1128\/msphere.00345-22","article-title":"Phage resistance accompanies reduced fitness of uropathogenic Escherichia coli in the urinary environment","volume":"7","author":"Zulk","year":"2022","journal-title":"mSphere"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.micres.2016.04.008","article-title":"Alternatives to overcoming bacterial resistances: State-of-the-art","volume":"191","author":"Rios","year":"2016","journal-title":"Microbiol. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3389\/fphar.2019.00692","article-title":"Prospects for the use of new technologies to combat multidrug-resistant bacteria","volume":"10","author":"Lima","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Filippov, A., Sergueev, K.V., He, Y., Huang, X.Z., Gnade, B.T., Mueller, A.J., Fernandez-Prada, C., and Nikolich, M.P. (2011). Bacteriophage-resistant mutants in Yersinia pestis: Identification of phage receptors and attenuation for mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025486"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virusres.2016.09.019","article-title":"Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli","volume":"227","author":"Pereira","year":"2016","journal-title":"Virus Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wright, R.C., Friman, V.-P., Smith, M.C.M., and Brockhurst, M.A. (2018). Cross-resistance is modular in bacteria\u2013phage interactions. PLoS Biol., 16.","DOI":"10.1371\/journal.pbio.2006057"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3390\/microorganisms7090286","article-title":"Efficiency of phage \u03c66 for biocontrol of Pseudomonas syringae pv. syringae: An in vitro preliminary study","volume":"7","author":"Pinheiro","year":"2019","journal-title":"Microorganisms"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Duarte, J., Pereira, C., Costa, P., and Almeida, A. (2021). Bacteriophages with potential to inactivate Aeromonas hydrophila in cockles: In vitro and in vivo preliminary studies. Antibiotics, 10.","DOI":"10.3390\/antibiotics10060710"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"734423","DOI":"10.1016\/j.aquaculture.2019.734423","article-title":"Overcoming the challenges of phage therapy for industrial aquaculture: A review","volume":"513","author":"Culot","year":"2019","journal-title":"Aquaculture"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.scitotenv.2018.05.229","article-title":"Fate of cefotaxime-resistant Enterobacteriaceae and ESBL-producers over a full-scale wastewater treatment process with UV disinfection","volume":"639","author":"Silva","year":"2018","journal-title":"Sci. Total Environ."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.virusres.2016.04.020","article-title":"Bacteriophages with potential to inactivate Salmonella Typhimurium: Use of single phage suspensions and phage cocktails","volume":"220","author":"Pereira","year":"2016","journal-title":"Virus Res."},{"key":"ref_72","unstructured":"Adams, M.H. (1959). Bacteriophages, John Wiley and Sons Inc."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Jako\u010di\u016bn\u0117, D., and Moodley, A. (2018). A Rapid bacteriophage DNA extraction method. Methods Protoc., 1.","DOI":"10.3390\/mps1030027"},{"key":"ref_74","unstructured":"Sambrook, J., and Russel, D.W. (2001). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: A flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J. Comput. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/bioinformatics\/btv383","article-title":"Bandage: Interactive visualization of de novo genome assemblies","volume":"31","author":"Wick","year":"2015","journal-title":"Bioinformatics"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Bushnell, B., Rood, J., and Singer, E. (2017). BBMerge\u2014Accurate paired shotgun read merging via overlap. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185056"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Walker, B.J., Abeel, T., Shea, T., Priest, M., Abouelliel, A., Sakthikumar, S., Cuomo, C.A., Zeng, Q., Wortman, J., and Young, S.K. (2014). Pilon: An integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112963"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1038\/s41598-017-07910-5","article-title":"PhageTerm: A tool for fast and accurate determination of phage termini and packaging mechanism using next-generation sequencing data","volume":"7","author":"Garneau","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/phage.2021.0015","article-title":"Phage genome annotation: Where to begin and end","volume":"2","author":"Shen","year":"2021","journal-title":"Phage"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41587-020-00774-7","article-title":"CheckV assesses the quality and completeness of metagenome-assembled viral genomes","volume":"39","author":"Nayfach","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Bouras, G., Nepal, R., Houtak, G., Psaltis, A.J., Wormald, P.J., and Vreugde, S. (2023). Pharokka: A fast scalable bacteriophage annotation tool. Bioinformatics, 39.","DOI":"10.1093\/bioinformatics\/btac776"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Terzian, P., Ndela, E.O., Galiez, C., Lossouarn, J., Bucio, R.E.P., Mom, R., Toussaint, A., Petit, M.-A., and Enault, F. (2021). PHROG: Families of prokaryotic virus proteins clustered using remote homology. NAR Genom. Bioinform., 3.","DOI":"10.1093\/nargab\/lqab067"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12985-020-01485-w","article-title":"Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation","volume":"18","author":"Zurabov","year":"2021","journal-title":"Virol. J."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/2\/195\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:02:05Z","timestamp":1760104925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/2\/195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":86,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["antibiotics13020195"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics13020195","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]}}}